论文部分内容阅读
It is well-known that risk for endometrial adenocar- cinoma increases in patients with high level of estrogen that is unopposed by progestin. And activation of extracellular signal-regulated kinase (ERK)1 and phosphatidylinositol 3 kinase/protein kinase B
It is well-known that risk for endometrial adenocar- cinoma increases in patients with high level of estrogen that is unopposed by progestin. And activation of extracellular signal-regulated kinase (ERK) 1 and phosphatidylinositol 3 kinase / protein kinase B